BioCentury
ARTICLE | Financial News

MannKind raises $61M registered direct offering

October 13, 2017 7:48 PM UTC

On Oct. 11, inhaled insulin company MannKind Corp. (NASDAQ:MNKD; Tel Aviv:MNKD) raised $61 million through the sale of 10.2 million shares at $6 in a registered direct offering....

BCIQ Company Profiles

MannKind Corp.